|
Index of reports
> Cases with Pyrexia (11)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Zemplar (Paricalcitol) where reactions include pyrexia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Zemplar side effects in male
Reported by a physician from Austria on 2012-06-21
Patient: male, weighing 98.0 kg (215.6 pounds)
Reactions: Dyspnoea, Bronchopneumonia, Staphylococcal Infection, Pyrexia, Inflammation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cefuroxime Sodium
Dosage: 1-0-0
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-10
End date: 2012-04-13
Zemplar
Dosage: 1-0-0
Administration route: Oral
Indication: Hyperparathyroidism Secondary
Start date: 2011-12-23
Other drugs received by patient: Opium / Naloxone TAB
Possible Zemplar side effects in female
Reported by a consumer/non-health professional from United States on 2012-05-29
Patient: female, weighing 77.2 kg (169.8 pounds)
Reactions: Blood Pressure Increased, Fatigue, Palpitations, Thirst, Pyrexia, Somnolence
Drug(s) suspected as cause:
Zemplar
Other drugs received by patient: Amlodipine Besylate; Atenolol; Flecainide Acetate; Warfarin Sodium; Simvastatin; Furosemide
Possible Zemplar side effects in male
Reported by a consumer/non-health professional from Colombia on 2012-05-17
Patient: male
Reactions: Abdominal Pain, Vomiting, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zemplar
Possible Zemplar side effects in male
Reported by a physician from Austria on 2012-05-01
Patient: male, weighing 97.0 kg (213.4 pounds)
Reactions: Dyspnoea, Bronchopneumonia, Staphylococcal Infection, Pyrexia, Inflammation
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zemplar
Dosage: 1-0-0
Administration route: Oral
Indication: Hyperparathyroidism Secondary
Start date: 2011-12-23
Cefuroxime Sodium
Dosage: 1-0-0
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-10
End date: 2012-04-13
Other drugs received by patient: Opium / Naloxone TAB
Possible Zemplar side effects in 68 year old male
Reported by a physician from Greece on 2012-02-03
Patient: 68 year old male, weighing 91.0 kg (200.2 pounds)
Reactions: Pneumonia, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zemplar
Other drugs received by patient: Atenolol; Atorvastatin; Furosemide; Caco3 (Calcium Carbonate); Lanthanum Carbonate; Darbepoetin; Amlodipine
Possible Zemplar side effects in female
Reported by a physician from Austria on 2011-12-21
Patient: female, weighing 56.0 kg (123.2 pounds)
Reactions: Abdominal Pain, Lymphadenopathy, Cardiomegaly, Abdominal Discomfort, Nutritional Condition Abnormal, Pertussis, C-Reactive Protein Increased, White Blood Cell Count Increased, Gastrointestinal Motility Disorder, Uterine Atrophy, Anaemia Haemolytic Autoimmune, Toxicity To Various Agents, Pulmonary Arteriopathy, Mitral Valve Sclerosis, Pancreatitis, Arteriosclerosis Coronary Artery, Essential Hypertension, Choking Sensation, Ovarian Atrophy, Body Temperature Increased, Aortic Arteriosclerosis, Decreased Appetite, Bronchitis Bacterial, Pancreatic Cyst, Ascites, Syncope, Hypothyroidism, Leukopenia, Weight Decreased, Tongue Discolouration, Bronchopneumonia, Angioplasty, Pyrexia, Hernia Obstructive, Pericardial Effusion, Autoimmune Thyroiditis, Intestinal Perforation, Type 1 Diabetes Mellitus, Cough, Procalcitonin Increased, Hiatus Hernia, Retinopathy, Renal and Pancreas Transplant Rejection, General Physical Health Deterioration, Renal Cyst, Body Temperature Decreased, Chronic Allograft Nephropathy, Insomnia, Ocular Icterus, Nervous System Disorder, Atelectasis, Effusion, Polyneuropathy, Fatigue, Pleural Effusion, Dizziness, Pancreatic Abscess, Atrial Fibrillation, Varicose Vein, Tongue Coated, Renal Failure Chronic, Pulmonary Fibrosis, Diarrhoea, Cytomegalovirus Infection, Infectious Peritonitis, Inflammatory Marker Increased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Zemplar
Other drugs received by patient: Renvela; Norvasc; Etalpha; Aspirin; Levothyroxine Sodium; Loveno Syringe; Zienam; Renvela; Neorecormon; Ganciclovir Sodium; Rapamune; Pantoprazole Sodium; Renvela; Bisoprolol Fumarate; Lovenox; Etalpha; Prograf; Xyzal
Possible Zemplar side effects in female
Reported by a physician from Czech Republic on 2011-11-16
Patient: female, weighing 80.0 kg (176.0 pounds)
Reactions: Injection Site Haematoma, Carotid Artery Insufficiency, Headache, Blood Parathyroid Hormone Decreased, Pyrexia, Cerebral Haemorrhage, C-Reactive Protein Increased, Oedema Peripheral, Blood Creatinine Increased, Arteriosclerosis, Urine Analysis Abnormal, Back Pain, Chest Discomfort, Fistula, Pain in Extremity, Urine Output Decreased, Hyperglycaemia, Hypotension, Troponin Increased, Sick Sinus Syndrome, Cerebral Hypoperfusion, Activities of Daily Living Impaired, Hypotonia, Dehydration, Mobility Decreased, Increased Upper Airway Secretion, Aphasia, Wheezing, Dependent Personality Disorder, Hemiparesis, Somnolence, Pallor, Cardiorenal Syndrome, Anticoagulant Therapy, Depression, Arteriovenous Fistula Site Complication, Vomiting, Dyspnoea, Nausea, Urinary Tract Infection, Ischaemic Stroke, Atrial Fibrillation, Renal Failure Chronic, Mineral Metabolism Disorder, Anxiety, Renal Impairment, Syncope, Renal Failure, Diarrhoea, Cardiac Failure, Bradycardia, Bronchitis, Gait Disturbance, Altered State of Consciousness, Meningioma, Inflammatory Marker Increased
Adverse event resulted in: death, hospitalization, disablity
Drug(s) suspected as cause:
Zemplar
Other drugs received by patient: Anopyrin; Egilok; Bromhexin; ACC Long; Furosemide; Secatoxin; Calcium Carbonicum; Zolpidem Tartrate; Cordarone; Tiapridal; Cefzil; NA Hco3; Vulmizolin; Levothyroxine Sodium; Novalgin; Lactulosa; Cipro; Dexamethasone Sodium Phosphate; Allopurinol; Dolmina; Dolsin; Erdomed; Tramadol Hydrochloride; Diazepam; Paralen; Fenolax; Mannitol; Atropine; Detralex; Fresubin; Fraxiparin; Heparoid; Codeine SUL TAB
Possible Zemplar side effects in 43 year old male
Reported by a physician from Greece on 2011-11-03
Patient: 43 year old male, weighing 72.0 kg (158.4 pounds)
Reactions: Dyspnoea, Pneumonia, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zemplar
Other drugs received by patient: Norvasc; Tacrolimus; Prednisolone; Sotalol HCL; Sotalol HCL; Salospir; Plavix; Myfortic
Possible Zemplar side effects in female
Reported by a physician from Austria on 2011-11-02
Patient: female, weighing 56.0 kg (123.2 pounds)
Reactions: Abdominal Pain, Lymphadenopathy, Cardiomegaly, Nutritional Condition Abnormal, Abdominal Discomfort, Pertussis, C-Reactive Protein Increased, White Blood Cell Count Increased, Gastrointestinal Motility Disorder, Anaemia Haemolytic Autoimmune, Uterine Atrophy, Toxicity To Various Agents, Pulmonary Arteriopathy, Mitral Valve Sclerosis, Pancreatitis, Arteriosclerosis Coronary Artery, Essential Hypertension, Choking Sensation, Ovarian Atrophy, Body Temperature Increased, Aortic Arteriosclerosis, Decreased Appetite, Pancreatic Cyst, Ascites, Syncope, Hypothyroidism, Leukopenia, Weight Decreased, Tongue Discolouration, Angioplasty, Pyrexia, Hernia Obstructive, Pericardial Effusion, Autoimmune Thyroiditis, Intestinal Perforation, Type 1 Diabetes Mellitus, Cough, Renal and Pancreas Transplant Rejection, Hiatus Hernia, Retinopathy, Procalcitonin Increased, General Physical Health Deterioration, Renal Cyst, Body Temperature Decreased, Chronic Allograft Nephropathy, Insomnia, Nervous System Disorder, Ocular Icterus, Atelectasis, Effusion, Polyneuropathy, Fatigue, Dizziness, Pleural Effusion, Pancreatic Abscess, Atrial Fibrillation, Varicose Vein, Renal Failure Chronic, Tongue Coated, Pulmonary Fibrosis, Diarrhoea, Cytomegalovirus Infection, Infectious Peritonitis, Inflammatory Marker Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zemplar
Other drugs received by patient: Lovenox; Levothyroxine Sodium; Etalpha; Xyzal; Aspirin; Prograf; Etalpha; Concor; Neorecormon; Renvela; Renvela; Norvasc; Rapamune Ueberz; Renvela; Pantoprazole Sodium; Loveno Syringe
Possible Zemplar side effects in female
Reported by a physician from Austria on 2011-10-27
Patient: female, weighing 56.0 kg (123.2 pounds)
Reactions: Abdominal Pain, Weight Decreased, Lymphadenopathy, Tongue Discolouration, Angioplasty, Pyrexia, Hernia Obstructive, Autoimmune Thyroiditis, Pericardial Effusion, Cardiac Disorder, Nutritional Condition Abnormal, Abdominal Discomfort, Intestinal Perforation, Pertussis, C-Reactive Protein Increased, Type 1 Diabetes Mellitus, White Blood Cell Count Increased, Cough, Retinopathy, Renal and Pancreas Transplant Rejection, Gastrointestinal Motility Disorder, Procalcitonin Increased, Hiatus Hernia, Anaemia Haemolytic Autoimmune, Uterine Atrophy, General Physical Health Deterioration, Renal Cyst, Body Temperature Decreased, Toxicity To Various Agents, Chronic Allograft Nephropathy, Insomnia, Ocular Icterus, Pancreatitis, Nervous System Disorder, Arteriosclerosis Coronary Artery, Essential Hypertension, Atelectasis, Choking Sensation, Ovarian Atrophy, Body Temperature Increased, Effusion, Polyneuropathy, Fatigue, Skin Ulcer, Aortic Arteriosclerosis, Pleural Effusion, Dizziness, Decreased Appetite, Pancreatic Abscess, Atrial Fibrillation, Pancreatic Cyst, Tongue Coated, Renal Failure Chronic, Ascites, Pulmonary Fibrosis, Lung Disorder, Syncope, Diarrhoea, Cytomegalovirus Infection, Hypothyroidism, Leukopenia, Infectious Peritonitis, Inflammatory Marker Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zemplar
Other drugs received by patient: Norvasc; Etalpha; Lovenox; Aspirin; Renvela; Neorecormon; Pantoprazole Sodium; Levothyroxine Sodium; Concor; Loveno Syringe; Renvela; Renvela; Etalpha; Rapamune Ueberz; Prograf; Xyzal
Possible Zemplar side effects in 67 year old female
Reported by a physician from Austria on 2011-10-26
Patient: 67 year old female, weighing 56.0 kg (123.2 pounds)
Reactions: Abdominal Pain, Weight Decreased, Tongue Discolouration, Lymphadenopathy, Pyrexia, Angioplasty, Hernia Obstructive, Autoimmune Thyroiditis, Pericardial Effusion, Cardiac Disorder, Nutritional Condition Abnormal, Abdominal Discomfort, Intestinal Perforation, Pertussis, C-Reactive Protein Increased, Type 1 Diabetes Mellitus, Cough, White Blood Cell Count Increased, Hiatus Hernia, Gastrointestinal Motility Disorder, Renal and Pancreas Transplant Rejection, Procalcitonin Increased, Retinopathy, Uterine Atrophy, General Physical Health Deterioration, Anaemia Haemolytic Autoimmune, Toxicity To Various Agents, Body Temperature Decreased, Renal Cyst, Chronic Allograft Nephropathy, Insomnia, Pancreatitis, Nervous System Disorder, Ocular Icterus, Arteriosclerosis Coronary Artery, Essential Hypertension, Choking Sensation, Atelectasis, Ovarian Atrophy, Body Temperature Increased, Effusion, Polyneuropathy, Fatigue, Skin Ulcer, Aortic Arteriosclerosis, Pleural Effusion, Dizziness, Decreased Appetite, Pancreatic Abscess, Pancreatic Cyst, Tongue Coated, Renal Failure Chronic, Pulmonary Fibrosis, Ascites, Lung Disorder, Syncope, Diarrhoea, Hypothyroidism, Cytomegalovirus Infection, Leukopenia, Infectious Peritonitis, Inflammatory Marker Increased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Zemplar
Other drugs received by patient: Lovenox; Neorecormon; Xyzal; Renvela; Renvela; Concor; Aspirin; Levothyroxine Sodium; Renvela; Etalpha; Norvasc; Pantoprazole Sodium; Loveno Syringe; Etalpha; Rapamune Ueberz; Prograf
|
